Related Experiment Video
Updated: Jul 16, 2026
06:39
Curcuminoid-Mediated Antimicrobial Photodynamic Therapy on a Murine Model of Oral Candidiasis
Published on: October 27, 2023
[Intestinal candidiasis: modern therapeutic tactics]
Summary
Intestinal candidiasis is a significant medical issue, diagnosed by identifying Candida in bowel tissue. Natamycin (Pimafucin) is the recommended treatment, acting locally without systemic side effects.
Area of Science:
- Gastroenterology
- Mycology
- Internal Medicine
Context:
- Intestinal candidiasis presents a growing challenge across multiple medical disciplines, including gastroenterology, gynecology, dentistry, and surgery.
- This condition is intrinsically linked to systemic candidiasis affecting other organs.
- Accurate diagnosis relies on identifying the filamentous form of Candida in bowel mucosal biopsies.
Purpose:
- To outline the diagnostic criteria for intestinal candidiasis.
- To identify the primary therapeutic agent for this condition.
Summary:
- The diagnostic approach for intestinal candidiasis involves microscopic examination of bowel mucosal tissue to detect the pseudomycelial form of Candida.
- Natamycin, marketed as Pimafucin, is the drug of choice for treating intestinal candidiasis.
- Pimafucin exerts a localized effect within the intestinal lumen, preventing systemic absorption and minimizing adverse effects.
Impact:
- Establishes a clear diagnostic pathway for intestinal candidiasis.
- Highlights the efficacy and safety of Natamycin (Pimafucin) as a targeted treatment.
- Reduces the burden of intestinal candidiasis across various medical specialties through effective management.
More Related Videos
Related Concept Videos
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
01:18Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.